CYP2B6 rs2279343: What Your Genotype Means for Drug Metabolism

What each genotype means

Understanding the rs2279343 Variant

The rs2279343 variant is a single nucleotide polymorphism (SNP) found within the CYP2B6 gene on chromosome 19. In genetic terms, this variant involves a change from an adenine (A) to a guanine (G) at a specific position in the DNA sequence. This change is often referred to as a Lys262Arg substitution, meaning it alters the amino acid sequence of the resulting protein. Because this SNP is located in a gene responsible for drug metabolism, it has been a subject of significant interest in the field of pharmacogenomics. Scientists study such variants to understand why people may experience different therapeutic effects or side effects when taking the same dose of a medication. It is important to note that while this variant is well-documented, it is just one of many factors, including age, diet, and other medications, that influence how your body processes drugs.

The Role of the CYP2B6 Gene

The CYP2B6 gene provides instructions for making an enzyme called cytochrome P450 2B6. This enzyme is part of the cytochrome P450 family, a group of proteins primarily found in the liver that are responsible for metabolizing, or breaking down, a wide range of substances. CYP2B6 is involved in the metabolism of several clinically important drugs, including the antiretroviral medication efavirenz, the antidepressant bupropion, and the opioid substitute methadone. By converting these drugs into forms that the body can easily eliminate, the enzyme helps regulate their concentration in the bloodstream. When the CYP2B6 gene contains variants like rs2279343, the resulting enzyme may have altered activity levels. This can lead to faster or slower clearance of drugs from the body, which is why clinicians sometimes consider genetic information when determining appropriate treatment plans for patients.

Research and Clinical Associations

Scientific research has established associations between the rs2279343 variant and the metabolism of specific drugs. For instance, studies have linked the G allele to changes in the metabolism of efavirenz, a medication used to treat HIV. Some evidence suggests that individuals carrying the G allele may experience different plasma concentrations of the drug, which has led to discussions about whether dosage adjustments might be beneficial in certain clinical contexts. Additionally, the variant has been studied in the context of nicotine metabolism and smoking behavior. While these associations are statistically significant in research settings, the clinical impact can vary between individuals. It is essential to understand that this evidence is considered moderate, and the presence of the variant does not guarantee a specific clinical outcome. Always consult with a healthcare provider or pharmacist to discuss how your genetic profile might relate to your specific medication regimen.

What You Can Do With This Information

Knowing your genotype for rs2279343 can be an interesting piece of your personal health puzzle, but it should not be used to make independent medical decisions. If you have received genetic testing results that include this variant, the most productive step is to share them with your doctor or a clinical pharmacist. These professionals are trained to interpret genetic data within the context of your overall health, including your medical history and current prescriptions. They can help determine if your genotype is relevant to your treatment and whether any adjustments to your medication or monitoring are necessary. Never stop or change the dosage of a prescribed medication based on genetic information without professional guidance. Genetic testing is a tool for personalized medicine, and its greatest value lies in the collaborative relationship between you and your healthcare team.

Frequently asked questions

Sources & further reading

Related variants in CYP2B6